Patients with early or intermediate dry AMD often explore new treatment options. While 2RT laser therapy requires careful patient selection, Valeda Light Therapy offers a non-invasive approach shown to stabilise or improve vision in many patients, without demonstrated retinal harm to date.

Is Valeda Light Therapy worth considering for Dry AMD? Backed by 4.5 years of clinical data, the LIGHTSITE IIIB trial offers real hope for maintaining vision and quality of life.